As shown in Figures 7A and C , the expression levels of AKT and p-AKT proteins in negative control, normal control and siRNA groups are not significantly different, suggesting that Arf6 downregulation suppressed the proliferation of prostate cancer cells not via the PI3K/AKT signaling pathway. This evidence concerns the gene ARF6 and prostate cancer.